Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • OKLO vs GSK✓SelectedUSD · GSKOKLO vs GSK performance historyLatest closeAs of-3.72%11/16
Stock and ETF performance explorer

OKLO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+132.2%
GSK return
+46.9%
Excess return
+85.3%
Maximum drawdown
-89.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.7%-0.1%-3.6%-3.7%
7D-14.2%-1.3%-12.9%-14.2%
30D-17.7%+2.7%-20.4%-17.6%
3M-48.1%+2.7%-50.8%-48.0%
6M-63.0%+3.3%-66.3%-62.9%
YTD-67.9%+6.5%-74.4%-67.7%
1Y-76.4%+10.7%-87.1%-76.2%
3Y+123.2%+64.4%+58.8%+121.9%
5Y+132.2%+46.7%+85.5%+131.5%
All+132.2%+46.9%+85.3%+131.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling